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Abstract
Background: Health care providers and educators who seek to create health promotion
programs and individualized comprehensive care plans for women with schizophrenia are
hindered by the lack of data to guide their efforts.
Purpose:  This study tested the hypothesis that women with schizophrenia adhere to
mammography screening guidelines at the same rate as other same-age women. The study also
investigated the validity of the Health Belief (HB) and Stages of Change (SOC) models for breast
cancer screening among women with schizophrenia.
Methods: Socio-demographic and clinical variables, as well as knowledge, attitudes, and barriers
were assessed as a function of stage of change related to breast cancer screening in 46 women
with schizophrenia.
Results: Women with schizophrenia were statistically less likely to be adherent to the screening
recommendations than those without schizophrenia. Some support was found for the validity of
the HB and SOC models for breast cancer screening in women with schizophrenia. Women in
the Precontemplation stage had significantly higher negative attitude scores compared to
Contemplation and Action/Maintenance stages (59.7, 45.7, and 43.2, respectively), and there was
a trend for more barriers in the Precontemplation group (4.6, 2.6, 2.7 respectively).
Conclusion: Given the small sample size, further research on the rates of breast cancer
screening in women with schizophrenia is warranted. Nonetheless, these data suggest that
providers who care for women with schizophrenia may need to make take additional measures
to ensure that this population receives appropriate screening so as to not put them at greater
risk for a late-stage diagnosis of breast cancer. Furthermore, these pilot data suggest that HB and
SOC theory-based interventions may be valid for increasing mammography rates in women with
schizophrenia.
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Background
In the last decade, the overall incidence of breast cancer
has remained stable, while mortality has decreased [1].
Some, but not all, studies showed that rates of late-stage
diagnoses have decreased [2-5]. At least a portion of the
success in reducing breast cancer-related morbidity and
mortality can be attributed to the early detection afforded
by regular use of screening mammography among women
40 and older. Although breast cancer screening has been
steadily increasing since the late 1980's and overall rates
are approaching the defined targets [i.e., Healthy People
2010 [6]], use of mammography in some groups of
women is still low [1]. Underserved women include those
who are poor, less educated, non-Caucasian, living in
rural areas [7], lacking health insurance or a usual source
of care, physically challenged [8], coping with cognitive
limitations [9], and diagnosed with severe and persistent
psychiatric disorders, such as schizophrenia and related
psychotic disorders [10,11].
Researchers have developed specific interventions to
increase breast cancer screening in many of these under-
represented groups [12]. However, there remains a rela-
tive lack of studies investigating the breast cancer screen-
ing rates of women with psychotic disorders. Little is
known about the knowledge and benefits of, attitudes
toward, and barriers to mammography in women with
schizophrenia, and there is a similar paucity of interven-
tions to promote screening in this group [13].
Moreover, older women with psychosis may be at
increased risk for breast cancer because of factors related
to their psychiatric disorder or its treatment. Some [14-
16], but not all [17-21], studies have found an increased
risk of breast cancer in women with schizophrenia, the
reasons for which are not yet clear. This may, in part, be
due to the fact that women with schizophrenia are more
likely to have the general risk factors commonly associ-
ated with increased incidence of breast cancer, such as
nulliparity, obesity, high fat diet, or physical inactivity
[22,23]. In addition, there may be factors specifically
related to schizophrenia and its treatment that increase
risk for breast cancer [24]. Barriers to medical care, such as
fear of condemnation, stigma, and limited finances, also
restricted access to early detection and treatment among
women with schizophrenia [25].
To understand the use of mammography, researchers have
employed constructs from theories of health behavior
change, such as the Health Belief (HB) model [26] and the
Stages of Change (SOC) model [27]. The Health Belief
model [28] considers health behavior a result of the inter-
play among variables that include perceived susceptibility
to illness, perceived severity of illness, perceived benefits
of taking health action, perceived barriers to taking action,
and repetitive cues to health action. According to this
model, women are more likely to undergo mammogra-
phy if they believe that they are susceptible to breast can-
cer, consider its consequences severe, are aware of the
benefits of screening, perceive that the benefits outweigh
the barriers, and receive repeated cues to be screened. Per-
ceived susceptibility and perceived barriers are usually the
most important predictors of preventive health behavior,
including mammography use [29,30], and most, but not
all, studies testing the HB model in mammography have
supported the model [30-42].
The Stages of Change Model has also been useful in
understanding breast cancer screening. Specifically, the
stages of adoption of the behavior and decisional balance
have been used to predict rates of mammography in the
general population [43-45]. The model proposes that peo-
ple pass through a series of progressively more committed
stages in the course of changing a health-related behavior:
Precontemplation (not even thinking about the target
behavior), Contemplation (currently not doing the
behavior, but considering the adoption of the behavior),
Action (beginning to adopt the behavior), and Mainte-
nance (sustaining the behavior over time). An algorithm
was developed for mammography stages of change that
included these five stages, as well as two others, Relapse
Precontemplation, and Relapse Contemplation that differ
from the Precontemplation and Contemplation stages, in
that women in these categories have had a mammogram
in the past, are not currently on schedule, and may or may
not be considering undergoing mammography in the next
six months [46,45]. In this algorithm, the criteria for scor-
ing positively (having a mammogram) were age depend-
ent: women age 40–49 were expected to be screened at
least every two years and women aged 50 and older,
yearly. Several investigators have applied the concept of
stages of change to assessing the efficacy of interventions
to improve mammography adherence [44,47,48].
Decisional Balance, another construct of the SOC model,
has been applied to mammography. It is a summary index
derived from perceived positive (pros) and perceived neg-
ative (cons) features of the target behavior [49]. The
model hypothesizes that people in the Action and Main-
tenance stages have a positive decisional balance
(pros>cons) and that people in Pre-contemplation have a
negative balance (cons>pros). Persons in Contemplation
have a decisional balance that falls between Pre-contem-
plation and Action and are expected to be closer to neutral
or zero point of equal pros and cons.
To date, there has been limited application of the SOC
model to promoting recommended health behaviors in
persons with schizophrenia. Some have examined stages
of change to address alcohol use in schizophrenia withBMC Psychiatry 2006, 6:49 http://www.biomedcentral.com/1471-244X/6/49
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mixed results [50-52]. Others have reported validity of the
model with respect to smoking cessation in schizophrenia
[53]. Some have criticized the application of SOC model
in persons with schizophrenia because some of these indi-
viduals lack several of the essential characteristics posited
by the theory that are necessary to change behavior–
namely, motivation and self-control, cognitive and behav-
ioral coping skills, and social support [54]. The success of
the SOC model, however, may be dependent on the
behavior targeted for change and the characteristics of the
sample. For example, eliminating addictive behaviors,
such as substance use, may be very different from promot-
ing preventive health behaviors, such as increasing the use
of mammography. Furthermore, dually diagnosed per-
sons (schizophrenia and substance use disorder) often
have the more severe symptoms [55], poorer medication
compliance [56], and increased use of institutional and
emergency services [57,58] than non-substance addicted
persons, suggesting that these individuals are not repre-
sentative of all persons with schizophrenia.
At least one study has examined constructs of the HB and
SOC models jointly for mammography use in a predomi-
nantly Caucasian middle class population. Champion
and colleagues [36] found that women in the Action and
Maintenance stages perceived significantly higher suscep-
tibility, more seriousness, fewer barriers, and more bene-
fits than those in the Pre-contemplation or
Contemplation stages. No studies were found that
described the relationship among knowledge and benefits
of attitudes toward, and barriers to, breast cancer screen-
ing and stage of change in middle-aged women with
schizophrenia, a group that possesses many risk factors
for breast cancer.
The purpose of this study was to test the following three
hypotheses: 1) women with schizophrenia are less likely
to adhere to recommended screening guidelines than
other same-age women; 2) the Health Belief and Stages of
Change models will be a viable models for predicting
breast cancer screening among women with schizophre-
nia; and 3) women with schizophrenia who are classified
as being in the Precontemplation or Contemplation stage
will have lower scores on their test of knowledge and ben-
efits, more barriers to cancer screening, and more negative
attitudes toward cancer screening (more negative deci-
sional balance scores) than women with schizophrenia in
the Action or Maintenance stages, a pattern that is typical
in the general population.
Methods
Participant Eligibility
Women were eligible for the study if they had a DSM-IV
[59] diagnosis of schizophrenia or schizoaffective disor-
der, were at least 40 years of age, were community-dwell-
ing outpatients under the care of a psychiatrist, had no
known diagnosis of dementia, had a history negative for
breast cancer, were psychiatrically and medically stable,
and were able to give informed consent.
Informed Consent
All women gave written, informed consent, following a
protocol approved by the researchers' Institutional Review
Board. Trained research assistants met with each woman
to conduct the interviews and to administer verbally the
five survey instruments. All data were based on self-report
unless the participant could not provide key information,
such as date of last mammogram. In these cases, medical
records were reviewed with the subject's consent.
Survey Instruments
Socio-demographic and Clinical Information
Socio-demographic information, medical history, and
gynecology service use were gathered from face-to-face
interviews. The Positive and Negative Syndrome Scale
(PANSS) [60] was used to assess positive and negative
symptoms of schizophrenia, as well as general psychopa-
thology.
Stage of Change for Mammography
The stage of change definitions for mammography fol-
lowed the age-based recommendations; at least every two
years for ages 40–49 and yearly for age 50 and older
[44,46]. Precomtemplation stage consisted of women
who never had a mammogram and were not considering
receiving one; whereas Relapse Contemplation included
women who had undergone mammography in the past
but had not had one in the recommended time frame and
were not considering having one. Women were classified
as being in the Contemplation stage if they had never had
a mammogram but were considering undergoing mam-
mography, and similarly they were categorized as Relapse
Contemplation if they had a mammogram in the past but
not within the recommended time frame and were con-
sidering having one. Action stage was defined as being
adherent with the screening recommendations, and Main-
tenance stage was defined as having had more than one
mammogram according to the recommendations.
Knowledge toward and Benefits of Breast Cancer and Barriers to 
Screening
Knowledge and benefits about breast cancer and mam-
mography were assessed using the questionnaire devel-
oped by Skinner and colleagues [61]. It consisted of eight
true/false items about breast cancer knowledge and five
items about perceived benefits of mammography. A total
score was computed by summing the number of correct
responses to both the knowledge and benefit items for a
maximum score of 13.BMC Psychiatry 2006, 6:49 http://www.biomedcentral.com/1471-244X/6/49
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The measures developed by Rakowski and colleagues [49]
were used to measure decisional balance for mammogra-
phy. It is a summary index that quantifies the net results
of balancing of pros and cons for adopting a new health
behavior. The women rated their agreement according to
a 5-point Likert-type scale (1 = strongly disagree to 5 =
strongly agree) with each of six "pro" statements and
seven "con" statements for mammography. An index of
decisional balance was calculated by transforming the
"pro" index and "con" index for the mammography scales
into percents, and subtracting the "con" percent from the
"pro" percent. Positive decisional balance scores indicate
a favorable assessment of pros versus cons (historically
characteristic of a person already performing the behav-
ior); negative values indicate a more unfavorable assess-
ment (historically characteristic of persons not yet
committed to the behavior). Decisional balance of about
zero represents a mixed perspective of positive and nega-
tive opinions, which is typical among persons contem-
plating the behavior.
The Health Belief model purports that a person also con-
siders the barriers in deciding whether or not to adopt a
new health behavior. Some barriers are attitudinal, while
others are instrumental (e.g., cost, transportation). The
heterogeneity in the types of barriers necessitates that they
be examined separately from knowledge (perceived sus-
ceptibility, severity and benefits) or attitudes (decisional
balance). Participants also responded to a list of 15 items
representing possible barriers to mammography that was
used by Skinner and colleagues [46]. The total score was
the total number of items positively endorsed.
Analysis
Descriptive characteristics of the sample by stage of
change were analyzed using Chi-square tests for categori-
cal variables and analysis of variance (ANOVA) for contin-
uous variables. Separate ANOVAs were conducted for
each of the dependent variables (total score on the test of
knowledge and benefits; total percent positive attitude,
total percent negative, the decisional index, and number
of barriers), and Spearman rho correlations were con-
ducted to assess the relationship between the dependent
variable and stage of change. Post-hoc analysis of individ-
ual items of the Decisional Balance and Barriers question-
naires for mammography were conducted using Chi-
square tests. For this analysis, the 5-point Likkert scale of
the Decisional Balance questionnaire was collapsed into
two categories: agree and disagree. All tests were two-
tailed with alpha set at 0.05. The slightly increased exper-
iment-wide Type I error that might result by using an
alpha of 0.05 for each dependent variable, rather than
alpha of 0.01 (Bonferroni corrected), outweighed the pos-
sible Type II error, given the importance of understanding
knowledge and benefits of attitudes toward, and barriers
to, breast cancer screening and developing interventions
to reduce risk for breast cancer for this group.
Results
Subjects were a sample of convenience and consisted of
46 women between the ages of 44 and 72 years with a
mean age of 52.9 (SD = 6.0 years). They were predomi-
nantly Caucasian (80%), and all were participating in on-
going studies at a university-affiliated research center. The
majority (65%) had never been married, and they aver-
aged 12.3 (± 1.9) years of education. Most participants
(73.3%) resided in an assisted care facility.
Nearly all of the women (88.8%) reported that they had
insurance, a primary care physician (91.1%), and annual
physical examinations (73.3%). Less than half of the
women reported receiving one or more gender-specific
preventive screenings within the past year: pelvic exami-
nation (45.7%), Pap test (43.5%), or mammogram
(41.3%), and just over one third received none of the
screenings. Twenty eight percent of the women were
under the age of 50. Since the screening guidelines are less
rigorous for this age group, the mammography rates for
women under age 50 were examined separately. Table 1
shows that more of the younger group reported having
mammograms than the older group; therefore, we com-
bined both age groups for analysis. To compare annual
rates of mammography in women with schizophrenia to
reported rates in 40–64 year old women in California, the
data were analyzed using the same aged subjects. Thirty
seven percent of the women with schizophrenia reported
having an annual mammogram.
Using the algorithm developed by Skinner and colleagues
[46], only 4.3% (n = 2) of women with schizophrenia
were classified as being in the Precontemplation stage;
while, 17.4% (n = 8) were rated as being in the Relapse
Precontemplation stage. None of the women met the def-
inition for the Contemplation stage, 15.2% (n = 7) were
categorized as being in Relapse Contemplation, 13.1% (n
= 6) met criteria for the Action and 50% (n = 23) were
classified as being in the Maintenance stage. Given the
small sample sizes, the Precontemplation stage was com-
bined with the Relapse Precontemplation stage (n = 10)
and the Action stage was combined with the Maintenance
stage (n = 29). Relapse Contemplation remained a sepa-
rate category (n = 7). Three groups were created: 1)
women who were not considering having a mammogram
in the future whether or not they had one in the past
(Precomtemplation, 21.7%); 2) women who underwent
mammography more than two years ago, who were con-
sidering having another (Contemplation, 15.2%); and 3)
women who had a mammogram in at least the past two
years and who regularly underwent age-appropriate
screening (Action/Maintenance, 63%).BMC Psychiatry 2006, 6:49 http://www.biomedcentral.com/1471-244X/6/49
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Results of ANOVAs revealed that there were no significant
differences among the groups on knowledge and benefits
scores or number of barriers, although the barriers to
receiving mammograms reported by the women differed
at a trend level (p = 0.081; see Table 2). While the Positive
Decisional Balance scores did not differ among the
groups, Negative Decisional Balance scores demonstrated
a significant difference among the stages. Women in the
Precontemplation group had significantly more negative
attitudes toward mammography than the other groups,
although all groups demonstrated negative attitudes
toward screening. The Decisional Balance Index also dif-
fered significantly between the Precontemplation and the
other two groups. There were no significant differences
among the stages of change on any of the demographic or
clinical variables.
To further examine the relationship between measures of
decisional balance and stage of change, Spearman rho cor-
relations were conducted. The Negative Decisional Bal-
ance score, and consequently the Decisional Balance
Index, were found to be significantly inversely associated
with stage of change (rho = -.394, p = .007 and rho = -
.391, p = .007, respectively). In contrast, Positive Deci-
sional Balance score, Knowledge score, and Barrier score
were not associated with stage of change. Post-hoc analy-
sis of the individual items on the Decisional Balance ques-
tionnaire revealed that 55.6% of women in the
Precontemplation group believed that a mammogram
was not needed if a clinical breast exam was preformed
compared to 18.5% of the women in the Action/Mainte-
nance group and none in the Contemplation group. (Chi-
square = 7.292, d.f, = 2, p = .026.) Furthermore, all of the
women in the Precontemplation group indicated that
they would not have a mammogram if the doctor seemed
to doubt that one was needed. In contrast, only 57.1% of
the Contemplation group and 40.7% of the Action/Main-
tenance group endorsed this negative attitude (Chi-square
= 7.892, d.f. = 2, p = .019.) No other significant differences
were found among the groups. Lending further support
for this observation, post-hoc analysis of the 13-item Bar-
riers questionnaire also disclosed a significantly greater
propensity for women in the Precontemplation group to
not have a mammogram if a clinical breast exam was per-
formed or if the doctor doubted the need for one.
Discussion
We found that the proportion of women who received
mammograms in the past year was lower than the rate
reported for the general population in California (41.3%
versus 60.5% for ages 40–64) [62] and more closely
aligned with screening rates for minority populations liv-
ing in the same community [63-65]. The low rate of
screening may be considered even more disconcerting in
view of the fact that nearly all of the women reported that
they had insurance (88.8%), a primary care physician
(91.1%), and annual physical examinations (73.3%).
This low screening rate places them at a considerably
greater risk of having a breast cancer discovered at a late
stage, thereby supporting the first hypothesis.
As further support of the first hypothesis, only 41%
endorsed having annual mammograms and only 63% of
women reported undergoing mammography within the
Table 1: Means (SD) or percentages for socio-demographic, clinical, and service use by stage of adoption in older women with 
schizophrenia.
Precontemplation 
(n = 10)
Contemplation 
(n= 7)
Action/Maintenance 
(n = 29)
F or χ2 Value p-value
Age (years) 52.7 (4.4) 52.3 (6.8) 53.1 (6.4) 2.34 .940 --
Ethnicity (% Cauc.) 90.0 85.7 75.9 1.65 .800 --
Marital Status (% ever married) 60.0 28.6 75.9 5.71 .057 --
Education (years) 13.1 (2.5) 11.3 (0.95) 12.2 (1.8) 2.00 0.149 --
Living Situation (% Assisted Living) 80.0 71.4 69.0 1.12 .892 --
PANSS Positive 15.8 (5.5) 12.3 (5.6) 11.9 (4.6) 2.38 0.105 --
PANSS Negative 15.9 (4.7) 11.9 (2.9) 12.4 (4.7) 2.56 0.089 --
PANSS General 29.7 (7.42) 25.0 (3.4) 25.0 (5.8) 2.51 0.093 --
Insurance (%yes) 80 100 89.2 1.68 .432 --
Primary Care Provider (%yes) 70.0 100 96.6 7.15 .028 P<C, A/M
Annual Physical Exam (%yes) 30 42.9 96.4 21.35 .000 P, C<A/M
Annual Pelvic Exam (%yes) 20 28.6 58.6 5.44 .066 --
Annual Pap (%yes) 20 28.6 55.2 4.49 .106 --
Annual Mammogram (%yes)  
Age≥50 years
0 0 60.0 12.26 .002 P, C<A/M
Annual Mammogram (%yes)  
Age<50 years
0 0 77.8 6.74 .034 P, C<A/M
Precomtemplation; C = Contemplation; A/M = Action/MaintenanceBMC Psychiatry 2006, 6:49 http://www.biomedcentral.com/1471-244X/6/49
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past two years (as defined by being in the Action or Main-
tenance stage), a rate lower than that seen in the general
population and consistent with other research examining
preventive care in women with severe mental illness
[11,66]. One study found that 62% of their sample of
women with schizophrenia had mammograms in the last
two years [11]. Another study reported that women with
schizophrenia and a low-income comparison group
received similar preventive services, but the rates of mam-
mography were not directly reported. It is not clear from
this study, whether these women with schizophrenia
received breast cancer screening at less than the recom-
mended rates because of low income, lack of a physician
referral, or due to their psychiatric illness. Further research
is warranted to develop effective interventions.
Data from this study also supported the second hypothe-
sis. We found some support for the validity of the Health
Belief and Stages of Change models for predicting mam-
mography adherence in women with schizophrenia.
From Champion and colleagues' [36] study of women
without schizophrenia, those in the Action and Mainte-
nance stage perceived significantly higher susceptibility,
more seriousness, fewer barriers, and more benefits than
those in the Precomptemplation or Comtemplation
stages. We did not find significant differences on measures
of knowledge and benefits of breast cancer screening in
our sample. However, women in the Precomtemplation
stage did report more barriers, which differed from the
other two stages of change categories, but at the trend level
only. We did, however, find support for the shift of Deci-
sional Balance over the stages of change, as predicted by
the Stages of Change model. Interestingly, positive atti-
tudes did not vary across stage of change. Negative atti-
tudes, however, were lower in the women who were
currently adhering to recommended mammography
screening guidelines, suggesting that interventions with
this group might be more effective if focused on ways of
reducing negative attitudes.
The third hypothesis was also supported. A pattern was
observed between knowledge and benefits of, attitudes
toward, and barriers to breast cancer screening by stage of
change in women with schizophrenia that has been
reported in non-psychiatric groups. The more negative
attitudes toward mammography were found in women
with schizophrenia who were categorized as being in the
Precontemplation stage, a finding that is consistent with
the Stage of Change Model.
Limitations
The findings from this study must be generalized with
caution because the sample is small, the study participants
were stable outpatients on antipsychotic medication, and
only one large metropolitan region was studied. Moreo-
ver, a self-selection bias cannot be overlooked; by agreeing
to participate in research, these women have set them-
selves apart from those women with schizophrenia who
refused the invitation to participate. Finally, this was a
cross-sectional study of stages of changes for mammogra-
phy. According to the theory, a longitudinal study is
needed to verify the shift in decisional balance over time.
Conclusion
This study found that rates of breast cancer screening in
women with schizophrenia were below the recom-
mended guidelines, which may put them at greater risk for
a late-stage breast cancer diagnosis. Moreover, this explor-
atory study of the application of the HB and SOC models
to mammography in older women with schizophrenia
suggests that these models may be useful for understand-
ing and promoting the use of breast cancer screening in
this population. Unlike the findings for reducing sub-
stance use behaviors in persons with schizophrenia, these
results suggest the HB and SOC models may have utility
in promoting some positive health behaviors in women
with schizophrenia.
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